Biohaven (BHVN) Operating Income (2021 - 2026)

Biohaven has reported Operating Income for 6 years, with the latest figure at -$130.4 million in Q1 2026.

• Quarterly Operating Income rose 41.13% year-over-year to -$130.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$654.2 million (up 29.15% YoY) and the FY2025 annual result came in at -$745.4 million, up 15.79% from the prior year.
• Operating Income improved to -$130.4 million in Q1 2026 per BHVN's latest filing, from -$142.7 million in the prior quarter.
• Over five years, Operating Income peaked at -$67.6 million in Q3 2022 and troughed at -$333.8 million in Q2 2024.
• A 5-year average of -$162.6 million and a median of -$169.4 million in 2025 frame the typical range for Operating Income.
• The sharpest annual moves came in 2022 and 2023: Operating Income slumped 319.42% in 2022, then surged 52.31% in 2023.
• Over 5 years, Operating Income stood at -$213.4 million in 2022, then rose by 27.97% to -$153.7 million in 2023, then fell by 23.56% to -$189.9 million in 2024, then advanced by 24.85% to -$142.7 million in 2025, then rose by 8.62% to -$130.4 million in 2026.
• According to Business Quant data, Operating Income over the past three periods registered -$130.4 million, -$142.7 million, and -$169.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.